Physician profile
Jake S Enos
NPI 1568021095
$7,902.51
in general payments reported to CMS, 2019-2025
12 companies · $6,013 in 2025
The $6,013 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $343 · 2021: $55.95 · 2022: $1,338 · 2023: $153 · 2025: $6,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,160 · Food and Beverage: $2,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,160.06 |
| Food and Beverage | $2,005.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,850.91 | 2020-2025 | Iconix, Salvation, Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $1,431.51 | 2025 | |
| Smith+Nephew, INC. | $1,321.89 | 2025 | Fast-Fix, Novostitch |
| Titan Surgical Group, LLC | $1,229.43 | 2022 | |
| Medical Device Business Services, INC. | $329.99 | 2020 | |
| Linvatec Corporation | $262.43 | 2025 | Biobrace 23mm |
| Sioux Surgical INC | $199.50 | 2025 | |
| Djo, LLC | $93.75 | 2025 | Aircast, Donjoy |
| Zimmer Biomet Holdings, INC. | $70.57 | 2022 | |
| Amgen INC. | $52.71 | 2025 | Evenity, Prolia |
| Depuy Synthes Sales INC. | $42.13 | 2023 | |
| Vericel Corporation | $17.69 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Enos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.